Cleared Traditional

Anprolene SteriTest (K170427) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K170427 · Andersen Sterilizers, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2017
Decision
260d
Days
Class 2
Risk

K170427 is an FDA 510(k) clearance for the Anprolene SteriTest. Classified as Indicator, Biological Sterilization Process (product code FRC), Class II - Special Controls.

Submitted by Andersen Sterilizers, Inc. (Haw River, US). The FDA issued a Cleared decision on October 31, 2017 after a review of 260 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.2800 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Andersen Sterilizers, Inc. devices

Submission Details

510(k) Number K170427 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2017
Decision Date October 31, 2017
Days to Decision 260 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
131d slower than avg
Panel avg: 129d · This submission: 260d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FRC Indicator, Biological Sterilization Process
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FRC Indicator, Biological Sterilization Process

All 89
Devices cleared under the same product code (FRC) and FDA review panel - the closest regulatory comparables to K170427.
Sporview VH202 BI
K171287 · Spsmedical Supply Corp. A Division of Cantel Medical · Feb 2018
3M Attest Super Rapid Readout Biological Indicator, 3M Attest Auto-reader, 3M Attest Auto-reader
K173584 · 3M Company · Jan 2018
Celerity 20 HP Biological Indicator
K172474 · STERIS Corporation · Dec 2017
VERIFY Assert VH2O2 Self-Contained Biological Indicator
K171504 · STERIS Corporation · Aug 2017
VERIFY Incubator for Assert VH2O2 Self-Contained Biological Indicator
K171587 · STERIS Corporation · Aug 2017
3M Attest Rapid Readout Biological Indicator, 3M Attest Auto-reader
K171003 · 3M Company · Jul 2017